Medy-Tox Inc. (086900.KQ) — Stock Score Summary

Medy-Tox Inc. (086900.KQ) has a MoatMap StockRank of 49/100 based on Quality (53/100), Value (51/100), and Momentum (32/100) factor scores. The current signal is HOLD. Medy-Tox is a Korean biopharma firm focused on botulinum toxin. While it has decent margins, it faces intense domestic litigation and price competition, and does not fit our CDMO pricing power theme.

Medy-Tox Inc. is a South Korean biopharmaceutical company that developed the world's first liquid-type botulinum toxin product, specializing in aesthetic and therapeutic biopharmaceuticals. The company's competitive moat is built on its proprietary R&D platforms, advanced biological manufacturing facilities, and strong market share in the global medical aesthetics market. Medy-Tox operates as a leading global player in the botulinum toxin and dermal filler segments.

Key Financial Metrics

Price$53.25
Market Cap$422M
P/E (TTM)34.03
P/E (Forward)14.67
Price/Book1.27
Return on Equity4.8%
Return on Invested Capital1.5%
Debt/Equity33.01
Gross Margin60.1%
Operating Margin12.1%
Revenue Growth-5.1%
Dividend Yield5.6%
Free Cash Flow$8K

Medy-Tox Inc. operates in the Biotechnology industry, part of the Healthcare sector (South Korea).

Frequently Asked Questions

What is Medy-Tox Inc.’s (086900.KQ) StockRank?
MoatMap’s StockRank for Medy-Tox Inc. (086900.KQ) is 49/100, with a Hold signal. It is a composite of Quality (53), Value (51), and Momentum (32) factor ranks across MoatMap’s 19,000+ stock universe.
Does Medy-Tox Inc. have an economic moat?
Medy-Tox Inc. (086900.KQ) has a Quality factor score of 53/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Medy-Tox Inc. a buy, hold, or sell?
MoatMap’s current signal for Medy-Tox Inc. (086900.KQ) is Hold, based on a StockRank of 49/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Medy-Tox Inc. in?
Medy-Tox Inc. (086900.KQ) operates in the Healthcare sector, specifically the Biotechnology industry (South Korea).
Browse all ranked stocks086900.KQ deep dive reportAI ChampionsHow we score stocksSense-check another stock